CN1579511A - Ready made traditional Chinese medicine for treating hyperplasia of mammary glans - Google Patents

Ready made traditional Chinese medicine for treating hyperplasia of mammary glans Download PDF

Info

Publication number
CN1579511A
CN1579511A CNA2004100241095A CN200410024109A CN1579511A CN 1579511 A CN1579511 A CN 1579511A CN A2004100241095 A CNA2004100241095 A CN A2004100241095A CN 200410024109 A CN200410024109 A CN 200410024109A CN 1579511 A CN1579511 A CN 1579511A
Authority
CN
China
Prior art keywords
hyperplasia
chinese patent
mammary glands
rhizoma
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2004100241095A
Other languages
Chinese (zh)
Other versions
CN1245210C (en
Inventor
姜兆俊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GAOHUA PHARMACEUTICAL FACTORY JINAN
Original Assignee
GAOHUA PHARMACEUTICAL FACTORY JINAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GAOHUA PHARMACEUTICAL FACTORY JINAN filed Critical GAOHUA PHARMACEUTICAL FACTORY JINAN
Priority to CNB2004100241095A priority Critical patent/CN1245210C/en
Publication of CN1579511A publication Critical patent/CN1579511A/en
Application granted granted Critical
Publication of CN1245210C publication Critical patent/CN1245210C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The invention provides a Chinese patent medicine for curing hyperplasia of mammary glands diseases, it is made up of ingredients with flowing weigh shares: self-heal 9-30g, devil's apron 9-30g, epimeddium 9-18g, crude oyster 9-30g, arisaema tuber 9-18g, zedoary 9-15g, bupleurum root 6-15g, pangolin 6-18g, xuanhu 9-15g, lagehead atractylodes 9-15g. the invention has functions of liver and kidney nourishing, qi ventilating and pain easing, calculus eliminating and so on. It can cure hyperplasia of mammary glands diseases casued by liver and kidney weak, and qi stasis and blood silt.

Description

A kind of Chinese patent medicine for the treatment of hyperplasia of mammary glands
Technical field
The present invention relates to medicine, is a kind of Chinese patent medicine for the treatment of hyperplasia of mammary glands
Background technology
Breast crack hypertrophy is that the women of child-bearing age's length is seen disease and frequently-occurring disease, accounts for the women of child-bearing age's 40%, and wherein, canceration rate is 8.6-14%, and Drug therapy generally adopts Western medicine or Chinese patent medicine, and the western medicine produce effects is fast, but side effect is big, and has recurrent.Because Chinese medicine has advantages such as treating both the principal and secondary aspects of a disease, be many patients' choice drug so adopt Chinese patent drugs for treatment.But existing Chinese medicine still exists deficiency: cure rate is low, is generally about 30%, and obvious effective rate is about 84-90% etc.
Summary of the invention
The objective of the invention is, a kind of Chinese patent medicine for the treatment of hyperplasia of mammary glands is provided, it can make its cure rate reach about 43%, and it is about 96% that total effective rate reaches, and relapse rate is low, has no side effect.
The present invention provides following technical scheme in order to finish goal of the invention: it is made up of the raw material of following weight parts: Spica Prunellae 9-30g, Thallus Laminariae (Thallus Eckloniae) 9-30g, Herba Epimedii 9-18g, Concha Ostreae 9-30g, Radix Asparagi 9-18g, Rhizoma Curcumae 9-15g, Radix Bupleuri 6-15g, Squama Manis 6-18g, Rhizoma Corydalis 9-15g, Rhizoma Atractylodis Macrocephalae 9-15g.Described Squama Manis 6-18g can respectively 50% substituting with Bombyx Batryticatus and Myrrha raw material weight.Described Thallus Laminariae (Thallus Eckloniae) 9-30g can have the 9-30g of extra large bath raw material weight to substitute.The consumption of described Squama Manis is 6-12g.Become to form among the present invention: Spica Prunellae 15-22g, Thallus Laminariae (Thallus Eckloniae) 15-22g, Herba Epimedii 12-16g, Concha Ostreae 15-20g, Radix Asparagi 12-16g, Rhizoma Curcumae 11-13g, Radix Bupleuri 8-13g, Squama Manis 8-10g, Rhizoma Corydalis 10-13g, Rhizoma Atractylodis Macrocephalae 8-12g by the raw material of following weight parts.Medicament of the present invention is a capsule.
The function of medicine of the present invention: soothing the liver the kidney invigorating, promoting the circulation of QI to relieve pain, blood circulation promoting and blood stasis dispelling, soft perpendicular eliminating stagnation, reducing phlegm disappears increases.Main treatment stagnation of liver-QI is suffered from a deficiency of the kidney, the hyperplasia of mammary glands of qi depression to blood stasis expectorant due to coagulating.The described raw material of medicine of the present invention, wherein grass cloth grass and Thallus Laminariae (Thallus Eckloniae) are in order to soft perpendicular eliminating stagnation, and reducing phlegm disappears increases to good medicine, wears Squama Manis, Rhizoma Curcumae, Concha Ostreae blood circulation promoting and blood stasis dispelling, soft perpendicular eliminating stagnation, reducing phlegm disappears increases.Join the Radix Bupleuri dispersing the stagnated live-QI to relieve the stagnation of QI, the Herba Epimedii kidney-replenishing that wets, Radix Asparagi nourishing kidney yin, both strengthened soft perpendicular eliminating stagnation, the power that reducing phlegm disappears increases, treating the liver is strongly fragrant again simultaneously suffers from a deficiency of the kidney morbidity originally, these two groups it be ministerial drug, and Rhizoma Atractylodis Macrocephalae spleen invigorating QI invigorating is to give birth to the mental disorder source extremely, and can restrict soft perpendicular eliminating stagnation, control the medicine impairing the spleen and stomach of blood and dissolving stasis, the Rhizoma Corydalis promoting the circulation of QI to relieve pain, blood circulation promoting and blood stasis dispelling is promoting flow of QI and blood analgesic good medicine, is adjuvant drug altogether, Radix Bupleuri remove to be transferred and to be reached mechanism of qi, outside the dispersing the stagnated live-QI to relieve the stagnation of QI, can guide the through Liver Channel disease of all medicines messenger drug of doing again.Raw material of the present invention wherein also has Res fungibiles, and the weight portion 9-15g of Pericarpium Citri Reticulatae Viride raw material can substitute Rhizoma Corydalis 9-15g, and the weight portion 9-15g of rhizoma sparganic raw material can substitute Rhizoma Curcumae 9-15g.Alternative materials of the present invention all can produce effects equivalent.
The present invention draws through clinical trial, its cure rate all is significantly improved than matched group (asparagine sheet, the peaceful granule of breast, RUHE SANJIE PIAN, PINGXIAO PIAN), be about 43.75%, total effective rate than matched group asparagine sheet 89%, peaceful particulate 90%, the RUHE SANJIE PIAN of breast 84.49%, 92.5% all being significantly increased of PINGXIAO PIAN, be about 98.57%, and relapse rate is low, is about 2.615%, has no side effect.
The specific embodiment
Manufacture method of the present invention all adopts the manufacture method of known Chinese patent medicine, and medicine of the present invention can adopt following arbitrary component to implement:
1, Spica Prunellae 12g, Thallus Laminariae (Thallus Eckloniae) 12g, Herba Epimedii 9g, Concha Ostreae 9g, Radix Asparagi 10g, Rhizoma Curcumae 9g, Radix Bupleuri 6g, Squama Manis 6g, Rhizoma Corydalis 9g, Rhizoma Atractylodis Macrocephalae 9g.
2, Spica Prunellae 18g, Thallus Laminariae (Thallus Eckloniae) 18g, Herba Epimedii 15g, Concha Ostreae 15g, Radix Asparagi 15g, Rhizoma Curcumae 12g, Radix Bupleuri 12g, Squama Manis 9g, Rhizoma Corydalis 12g, Rhizoma Atractylodis Macrocephalae 9g.
3, Spica Prunellae 25g, Thallus Laminariae (Thallus Eckloniae) 25g, Herba Epimedii 16g, Concha Ostreae 16g, Radix Asparagi 12g, Rhizoma Curcumae 12g, Radix Bupleuri 14g, Squama Manis 10g, Rhizoma Corydalis 13g, Rhizoma Atractylodis Macrocephalae 13g.
4, Spica Prunellae 18g, Thallus Laminariae (Thallus Eckloniae) 18g, Herba Epimedii 15g, Concha Ostreae 15g, Radix Asparagi 15g, Rhizoma Curcumae 12g, Radix Bupleuri 12g, Bombyx Batryticatus 9g, Myrrha 9g, Rhizoma Corydalis 12g, Rhizoma Atractylodis Macrocephalae 9g.
5, Spica Prunellae 18g, extra large bath 20g, Herba Epimedii 15g, Concha Ostreae 15g, Radix Asparagi 15g, Rhizoma Curcumae 12g, Radix Bupleuri 12g, Squama Manis 9g, Rhizoma Corydalis 12g, Rhizoma Atractylodis Macrocephalae 9g.
6, Spica Prunellae 18g, Thallus Laminariae (Thallus Eckloniae) 18g, Herba Epimedii 15g, Concha Ostreae 15g, Radix Asparagi 15g, Rhizoma Curcumae 12g, Radix Bupleuri 12g, Squama Manis 9g, Pericarpium Citri Reticulatae Viride 10g, Rhizoma Atractylodis Macrocephalae 9g.
7, Spica Prunellae 18g, Thallus Laminariae (Thallus Eckloniae) 18g, Herba Epimedii 15g, Concha Ostreae 15g, Radix Asparagi 15g, rhizoma sparganic 12g, Radix Bupleuri 12g, Squama Manis 9g, Rhizoma Corydalis 12g, Rhizoma Atractylodis Macrocephalae 9g.
8, Spica Prunellae 18g, extra large bath 18g, Herba Epimedii 15g, Concha Ostreae 15g, Radix Asparagi 15g, rhizoma sparganic 12g, Radix Bupleuri 12g, Bombyx Batryticatus 9g, Myrrha 9g, Pericarpium Citri Reticulatae Viride 12g, Rhizoma Atractylodis Macrocephalae 9g.

Claims (6)

1, a kind of Chinese patent medicine for the treatment of hyperplasia of mammary glands, it is characterized in that: it is made up of the raw material of following weight parts: Spica Prunellae 9-30g, Thallus Laminariae (Thallus Eckloniae) 9-30g, Herba Epimedii 9-18g, Concha Ostreae 9-30g, Radix Asparagi 9-18g, Rhizoma Curcumae 9-15g, Radix Bupleuri 6-15g, Squama Manis 6-18g, Rhizoma Corydalis 9-15g, Rhizoma Atractylodis Macrocephalae 9-15g.
2, a kind of Chinese patent medicine for the treatment of hyperplasia of mammary glands is characterized in that: described Squama Manis 6-18g can respectively 50% substituting with Bombyx Batryticatus and Myrrha raw material weight.
3, a kind of Chinese patent medicine for the treatment of hyperplasia of mammary glands is characterized in that: described Thallus Laminariae (Thallus Eckloniae) 9-30g can have the 9-30g of extra large bath raw material weight to substitute.
4, a kind of Chinese patent medicine for the treatment of hyperplasia of mammary glands, it is characterized in that: the consumption of described Squama Manis is 6-12g.
5, a kind of Chinese patent medicine for the treatment of hyperplasia of mammary glands, it is characterized in that: it is made up of the raw material of following weight parts: Spica Prunellae 15-22g, Thallus Laminariae (Thallus Eckloniae) 15-22g, Herba Epimedii 12-16g, Concha Ostreae 15-20g, Radix Asparagi 12-16g, Rhizoma Curcumae 11-13g, Radix Bupleuri 8-13g, Squama Manis 8-10g, Rhizoma Corydalis 10-13g, Rhizoma Atractylodis Macrocephalae 8-12g.
6, a kind of Chinese patent medicine for the treatment of hyperplasia of mammary glands, it is characterized in that: described medicament is a capsule.
CNB2004100241095A 2004-05-18 2004-05-18 Ready made traditional Chinese medicine for treating hyperplasia of mammary glans Expired - Fee Related CN1245210C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2004100241095A CN1245210C (en) 2004-05-18 2004-05-18 Ready made traditional Chinese medicine for treating hyperplasia of mammary glans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2004100241095A CN1245210C (en) 2004-05-18 2004-05-18 Ready made traditional Chinese medicine for treating hyperplasia of mammary glans

Publications (2)

Publication Number Publication Date
CN1579511A true CN1579511A (en) 2005-02-16
CN1245210C CN1245210C (en) 2006-03-15

Family

ID=34581965

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2004100241095A Expired - Fee Related CN1245210C (en) 2004-05-18 2004-05-18 Ready made traditional Chinese medicine for treating hyperplasia of mammary glans

Country Status (1)

Country Link
CN (1) CN1245210C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103191373A (en) * 2013-03-30 2013-07-10 侯萍 Traditional Chinese medicine for treating kidney deficiency type breast hyperplasia and preparation method of traditional Chinese medicine
CN104491544A (en) * 2014-12-25 2015-04-08 刘新霞 Traditional Chinese medicinal composition for treating breast hyperplasia caused by phlegm stagnation and sluggish
CN107019780A (en) * 2017-02-04 2017-08-08 洛阳士雄聚元医疗集团股份有限公司 A kind of Chinese medicine composition for treating the proliferation of mammary gland

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103191373A (en) * 2013-03-30 2013-07-10 侯萍 Traditional Chinese medicine for treating kidney deficiency type breast hyperplasia and preparation method of traditional Chinese medicine
CN103191373B (en) * 2013-03-30 2014-04-02 侯萍 Traditional Chinese medicine for treating kidney deficiency type breast hyperplasia and preparation method of traditional Chinese medicine
CN104491544A (en) * 2014-12-25 2015-04-08 刘新霞 Traditional Chinese medicinal composition for treating breast hyperplasia caused by phlegm stagnation and sluggish
CN107019780A (en) * 2017-02-04 2017-08-08 洛阳士雄聚元医疗集团股份有限公司 A kind of Chinese medicine composition for treating the proliferation of mammary gland

Also Published As

Publication number Publication date
CN1245210C (en) 2006-03-15

Similar Documents

Publication Publication Date Title
CN100509014C (en) Medicament for treating mammitis
CN101411848B (en) Black plaster for treating gland hyperplasia and preparation method thereof
CN101632820B (en) Intestinal obstruction removal pill
CN101024068A (en) Medicine for treating mastitis
CN1686506A (en) Medicine for treating mammary gland proliferation, its preparation method and application
CN101164573A (en) Traditional Chinese medicine for treating cold stagnation infantile hernia
CN1579511A (en) Ready made traditional Chinese medicine for treating hyperplasia of mammary glans
CN101130053A (en) Traditional Chinese medicine for treating exogenous injury type blood stasis headache
CN102697984B (en) Chinese medicinal external application preparation for treating acute mastitis
CN1478526A (en) Pure medicated wine
CN104606639B (en) A kind of Chinese medicine for treating acute mastitis milk obstruction
CN106236858A (en) The Chinese medicine formula of a kind ofization silt the kidney invigorating
CN1060078C (en) Chinese herbal medicine composition for curing malignant lymphoma
CN105770400A (en) Traditional Chinese medicine composition for treating puerperal infection
CN106362091A (en) Drug for treating mammary cancer
CN105456887A (en) Pharmaceutical for treating aplastic anemia
CN1291504A (en) Medicine for treating cirrhosis ascites
Zhuang et al. Thoughts on the treatment of cancer pain under the guidance of traditional Chinese medicine
CN102397511A (en) Medicament for treating flat wart
CN100396312C (en) Chinese medicine for treating rheumatic arthritis and preparing method
CN101596255B (en) Chinese medicament for preventing and curing leucemia
CN1163136A (en) Medicine for curing stone in urinary system
CN101953943A (en) Traditional Chinese medicine for treating chronic aplastic anemia
CN105663868A (en) Traditional Chinese medicinal composition for treating aplastic anemia
CN1278730C (en) Medicine for curing necrosis of femoral head

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060315

Termination date: 20140518